Emerging-market Oncology Sponsorship, RWE & Decentralized Trials
{
"content": "The intersection of shifting oncology investments, regulatory pragmatism and new operational models is reshaping how sponsors design and run trials in emerging markets. This deep dive synthesizes market research insights, regulatory trends and operational realities — with a focus ...
Robert Maxwell
Sep 29, 2025
breast cancer trials
heart failure therapeutics
maternal safety studies
Phrenic nerve stimulation
